Neither NMS nor rhabdomyolysis have been reported in association with entacapone treatment from controlled trials in which entacapone was discontinued abruptly.
Entakapooni järsu ärajätmise kontrollitud uuringute alusel ei ole teada ei maliigse neuroleptilise sündroomi ega rabdomüolüüsi juhtumeid.